Thomas E. Denion

Array ( [id] => 443241 [patent_doc_number] => 07256254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-14 [patent_title] => 'Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions' [patent_app_type] => utility [patent_app_number] => 11/298718 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7011 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/256/07256254.pdf [firstpage_image] =>[orig_patent_app_number] => 11298718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625287 [patent_doc_number] => 20060263792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Use of CR1-binding molecules in clearance and induction of immune responses' [patent_app_type] => utility [patent_app_number] => 11/263569 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24584 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263792.pdf [firstpage_image] =>[orig_patent_app_number] => 11263569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799362 [patent_doc_number] => 20060034865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Soluble MHC artificial antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 11/253009 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6183 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034865.pdf [firstpage_image] =>[orig_patent_app_number] => 11253009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840146 [patent_doc_number] => 07390490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-06-24 [patent_title] => 'Uses of anti-CX3CR1 antibody, anti-fractalkine antibody and fractalkine' [patent_app_type] => utility [patent_app_number] => 11/225829 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 8907 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390490.pdf [firstpage_image] =>[orig_patent_app_number] => 11225829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638078 [patent_doc_number] => 20060069052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'DNA vaccines that expresses mutant ADP-ribosyItransferase toxins which display reduced, or are devoid of, ADP-ribosyltransferase activity' [patent_app_type] => utility [patent_app_number] => 11/220410 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069052.pdf [firstpage_image] =>[orig_patent_app_number] => 11220410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977472 [patent_doc_number] => 20050287189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent' [patent_app_type] => utility [patent_app_number] => 11/205047 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13240 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287189.pdf [firstpage_image] =>[orig_patent_app_number] => 11205047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840144 [patent_doc_number] => 07390488 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-24 [patent_title] => 'Compositions and methods for producing vascular occlusion' [patent_app_type] => utility [patent_app_number] => 11/205045 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9359 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390488.pdf [firstpage_image] =>[orig_patent_app_number] => 11205045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 404801 [patent_doc_number] => 07288634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Isolated antibodies immunoreactive with synthetic peptides used to detect rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 11/165085 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3472 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288634.pdf [firstpage_image] =>[orig_patent_app_number] => 11165085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 829920 [patent_doc_number] => 07399471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-15 [patent_title] => 'Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/155775 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 35 [patent_no_of_words] => 9963 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399471.pdf [firstpage_image] =>[orig_patent_app_number] => 11155775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5771584 [patent_doc_number] => 20050267035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Peptide and polypeptide inhibitors of complement C1s' [patent_app_type] => utility [patent_app_number] => 11/156843 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18059 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267035.pdf [firstpage_image] =>[orig_patent_app_number] => 11156843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894828 [patent_doc_number] => 20060003367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Polynucleotides encoding a novel human Kupffer cell receptor protein, BGS-18' [patent_app_type] => utility [patent_app_number] => 11/152697 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 95253 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003367.pdf [firstpage_image] =>[orig_patent_app_number] => 11152697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894398 [patent_doc_number] => 20060002937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Methods for treating conditions associated with MASP-2 dependent complement activation' [patent_app_type] => utility [patent_app_number] => 11/150883 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 55207 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002937.pdf [firstpage_image] =>[orig_patent_app_number] => 11150883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766759 [patent_doc_number] => 20060018896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods for treating conditions associated with lectin-dependent complement activation' [patent_app_type] => utility [patent_app_number] => 11/150887 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 55359 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018896.pdf [firstpage_image] =>[orig_patent_app_number] => 11150887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650750 [patent_doc_number] => 07112327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-26 [patent_title] => 'Inhibition of complement activation' [patent_app_type] => utility [patent_app_number] => 11/139447 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 20308 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112327.pdf [firstpage_image] =>[orig_patent_app_number] => 11139447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925887 [patent_doc_number] => 20050239142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Assay method for group transfer reactions' [patent_app_type] => utility [patent_app_number] => 11/137947 [patent_app_country] => US [patent_app_date] => 2005-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23403 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239142.pdf [firstpage_image] =>[orig_patent_app_number] => 11137947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219984 [patent_doc_number] => 20050260661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Assays for the identification of modulators of MHC class II expression' [patent_app_type] => utility [patent_app_number] => 11/123269 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10159 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260661.pdf [firstpage_image] =>[orig_patent_app_number] => 11123269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7182736 [patent_doc_number] => 20050191288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Use of heparinase to decrease inflammatory responses' [patent_app_type] => utility [patent_app_number] => 11/118477 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17319 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191288.pdf [firstpage_image] =>[orig_patent_app_number] => 11118477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270628 [patent_doc_number] => 07563864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten' [patent_app_type] => utility [patent_app_number] => 11/115935 [patent_app_country] => US [patent_app_date] => 2005-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12915 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563864.pdf [firstpage_image] =>[orig_patent_app_number] => 11115935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111987 [patent_doc_number] => 20050209443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Flavor active modified thaumatin and monellin and methods for their production and use' [patent_app_type] => utility [patent_app_number] => 11/113441 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9757 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209443.pdf [firstpage_image] =>[orig_patent_app_number] => 11113441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649009 [patent_doc_number] => 20060134744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Method and apparatus for the production of soluble MHC antigens and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/099283 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 86 [patent_figures_cnt] => 86 [patent_no_of_words] => 47438 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134744.pdf [firstpage_image] =>[orig_patent_app_number] => 11099283 [rel_patent_id] =>[rel_patent_doc_number] =>)